Table 1.
Biochemical profile of compounds 1–4[a].
![]() | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Cpd | R | R1 | R2 | R3 | R4 | R5 | R6 | LSD1, IC50 (μM) | % inhibition at 100 μM | |
MAO A | MAO B | |||||||||
1a[b] | ![]() |
0.019 ± 0.004 | 97% | NI[c] | ||||||
1b | ![]() |
0.106 ± 0.020 | 96% | 37% | ||||||
1c | ![]() |
0.024 ± 0.004 | 96% | 50% | ||||||
1d | ![]() |
0.029 ± 0.005 | 95% | NI | ||||||
1e | ![]() |
0.051 ± 0.008 | 2% | 8% | ||||||
1f | ![]() |
0.054 ± 0.010 | 96% | 33% | ||||||
1g | ![]() |
0.038 ± 0.009 | 98% | 48% | ||||||
1h | ![]() |
0.043 ± 0.010 | 89% | 17% | ||||||
2a[d] | ![]() |
H | 0.149 ± 0.028 | 94% | 1% | |||||
2b[e] |
![]() meta |
H | 18.1 ± 2.9 | |||||||
2c | ![]() |
H | 0.459 ± 0.090 | |||||||
2d | ![]() |
H | 0.230 ± 0.042 | |||||||
2e | ![]() |
Br | 0.080 ± 0.026 | 71% | 29% | |||||
2f | ![]() |
H | 0.236 ± 0.039 | |||||||
2g | ![]() |
H | 0.130 ± 0.025 | 87% | 42% | |||||
2h | ![]() |
H | 0.280 ± 0.052 | |||||||
2i | ![]() |
H | 0.173 ± 0.028 | |||||||
2j | ![]() |
H | 0.767 ± 0.104 | |||||||
2k | ![]() |
H | 0.190 ± 0.030 | |||||||
2l | ![]() |
H | 0.083 ± 0.012 | |||||||
2m | ![]() |
H | 0.400 ± 0.072 | |||||||
2n | ![]() |
H | 0.236 ± 0.040 | |||||||
2o | ![]() |
H | 0.581 ± 0.071 | |||||||
3a | H | H | ![]() |
H | 0.090 ± 0.012 | 37% | 8% | |||
3b[f] | H | ![]() |
![]() |
H | 0.075 ± 0.011 | 76% | 78% | |||
3c | H | ![]() |
![]() |
H | 0.089 ± 0.010 | 69% | 55% | |||
3d[f] | H | ![]() |
H | H | 0.043 ± 0.010 | 46% | NI | |||
3e[f] | H | ![]() |
![]() |
H | 0.307 ± 0.069 | |||||
3f[f] | H | ![]() |
![]() |
H | 0.061 ± 0.011 | 21% | 17% | |||
3g[f] | H | ![]() |
![]() |
H | 0.089 ± 0.020 | 5% | 13% | |||
3h | H | ![]() |
![]() |
H | 0.143 ± 0.028 | |||||
3i | H | ![]() |
![]() |
H | 0.073 ± 0.011 | |||||
3j | ![]() |
H | H | H | 0.146 ± 0.022 | 72% | 17% | |||
3k | ![]() |
H | Br | H | 0.159 ± 0.034 | 94% | NI | |||
3l | ![]() |
H | ![]() |
H | 0.135 ± 0.029 | |||||
3m | ![]() |
H | H | ![]() |
3.9 ± 0.2 | |||||
3n | ![]() |
H | H | ![]() |
1.7 ± 0.05 | |||||
4a | 10.8 ± 1.1 | |||||||||
4b | 56.2 ± 7.8 | |||||||||
4c | NI | |||||||||
4d | NI | |||||||||
4e | NI | |||||||||
4f | NI | |||||||||
4g | NI | |||||||||
4h | NI | |||||||||
4i | NI | |||||||||
TCP | 11.2 ± 1.8 | 79% | 85% |
Data represent mean values of at least two separate experiments in duplicate.
Ref. [13a], added for comparison.
NI, no inhibition.
Reff. [13b, 19], added for comparison; compounds 2a,c-o have the Z-aminoacylamino substituent inserted at the C4 position of the TCP phenyl ring.
C3-substituted regioisomer of 2a.
Ref. [14], added for comparison.